Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study the Effect of Intravenous Hyoscine Butylbromide Injection on the Duration and Progress of First Stage Labour in High Risk Women

NCT03055390 is registered in ClinicalTrials.gov with Cairo University as lead sponsor.

NCT NCT03055390
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03055390 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study the Effect of Intravenous Hyoscine Butylbromide Injection on the Duration and Progress of First Stage Labour in High Risk Women
Lead sponsor
Cairo University
Phase
Phase 4
Overall status
Completed
Start date
February 11, 2017
Completion date
February 3, 2022
Enrollment
300 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

vaginal delivery